Berjame, Anecito S.

HRN: 08-68-89  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/01/2024
MUPIROCIN 2%, 15G (TUBE)
05/01/2024
05/08/2024
TOPICAL
Ointment
BID
Transglottic Carcinoma St.IV
Waiting Final Action 
05/02/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/02/2024
05/08/2024
IV
1.5g
Q6h
Transglottic Squamous Cell CA Stage IV C; S/P Tracheosomy
Waiting Final Action 
05/02/2024
AZITHROMYCIN 500MG TABLET (TAB)
05/02/2024
05/06/2024
ORAL
500mg
OD
Transglottic Squamous Cell CA Stage IV C; S/P Tracheosomy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: